Abstract
Introduction
Rhinitis and rhinosinusitis are commonly encountered in pregnant women. Intranasal corticosteroid (INCS) sprays are generally safe and effective in the treatment of these conditions in the general population. However, the use of some of these INCS sprays during pregnancy is still controversial.
Objective
To review the current literature about the safety of intranasal corticosteroid sprays during pregnancy.
Methodology
Using different search engines, each type of INCS was reviewed separately (triamcinolone, beclomethasone, budesonide, fluticasone propionate, fluticasone furoate, mometasone, and ciclesonide). A total of 51 full-length articles were examined for eligibility. After applying inclusion and exclusion criteria, a total of three articles were reviewed.
Results
No significant association with congenital organ malformations has been linked to intranasal use of beclomethasone, budesonide, fluticasone propionate, fluticasone furoate, or mometasone. Intranasal triamcinolone, however, has been found to have a significant association with respiratory tract defects. Data about the safety of intranasal ciclesonide during pregnancy are not available.
Conclusion
Lacking sufficient clinical trials on the use of intranasal corticosteroid sprays in pregnancy, we suggest that the intranasal use of fluticasone furoate, mometasone, and budesonide is safe if they are used at the recommended therapeutic dose after a proper medical evaluation. Intranasal fluticasone propionate might be a safe option in the absence of other INCS options due to its questionable efficacy during pregnancy. Risk-benefit ratio should always be considered before prescribing any intranasal corticosteroid sprays during pregnancy.
Similar content being viewed by others
References
Bende M, Gredmark T (1999) Nasal stuffiness during pregnancy. Laryngoscope 109:1108–1110. doi:10.1097/00005537-199907000-00018
Hamano N (1998) Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc 19:263–269
Schatz M, Zeiger RS (1988). Diagnosis and management of rhinitis during pregnancy. Allergy Asthma Proc 9(5):545–554
Wei W, Liu H, Kang D et al (2015) Non-surgical interventions for nasal congestion during pregnancy. Cochrane Database Syst Rev. doi:10.1002/14651858.CD011653
Yawn B, Knudtson M (2007) Treating asthma and comorbid allergic rhinitis in pregnancy. J Am Board Fam Med 20:289–298. doi:10.3122/jabfm.2007.03.060144
Ellegård EK (2006) Pregnancy rhinitis. Immunol Allergy Clin North Am 26:119–135. doi:10.1016/j.iac.2005.10.007
Incaudo GA (2004) Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation. Clin Rev Allergy Immunol 27:159–177. doi:10.1385/criai:27:2:159
Gilbey P, McGruthers L, Morency A-M, Shrim A (2012) Rhinosinusitis-related quality of life during pregnancy. Am J Rhinol Allergy 26:283–286. doi:10.2500/ajra.2012.26.3776
Caparroz FA, Gregorio LL, Bongiovanni G et al (2016) Rhinitis and pregnancy: literature review. Braz J Otorhinolaryngol 82:105–111. doi:10.1016/j.bjorl.2015.04.011
Pien GW, Schwab RJ (2004) Sleep disorders during pregnancy. Sleep 27:1405–1417
Kaiser HB, Liao Y, Diener P et al (2004) Triamcinolone acetonide and fluticasone propionate nasal sprays provide comparable relief of seasonal allergic rhinitis symptoms regardless of disease severity. Allergy Asthma Proc 25:423–428
Mak KK, Ku MS, Lu KH et al (2013) Comparison of mometasone furoate monohydrate (Nasonex) and fluticasone propionate (Flixonase) nasal sprays in the treatment of dust mite-sensitive children with perennial allergic rhinitis. Pediatr Neonatol 54:239–245. doi:10.1016/j.pedneo.2013.01.007
Newson-Smith G, Powell M, Baehre M et al (1997) A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur Arch Otorhinolaryngol 254:236–241
Trangsrud AJ, Whitaker AL, Small RE (2002) Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 22:1458–1467. doi:10.1592/phco.22.16.1458.33692
Weiner JM, Abramson MJ, Puy RM (1998) Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 317:1624–1629. doi:10.1136/bmj.317.7173.1624
Sheikh A, Panesar SS, Salvilla S (2009) Ear, nose, and throat disorders Hay fever in adolescents and adults Ear, nose, and throat disorders Hay fever in adolescents and adults. BMJ clinical evidence
Day J, Carrillo T (1998) Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol 102:902–908
Fokkens W, Lund V, Mullol J (2012) European position paper on rhinosinusitis and nasal polyps. Rhinology 1–136. doi:10.4193/Rhino50E2
Allen DB (2000) Systemic effects of intranasal steroids: an endocrinologist’s perspective. J Allergy Clin Immunol 106:S179-90. doi:10.1067/mai.2000.110038
Corren J (1999) Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol 104:S144-9. doi:10.1016/S0091-6749(99)70310-6
Boner AL (2001) Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J Allergy Clin Immunol 108:32–39. doi:10.1067/mai.2001.115564
Kim KT, Rabinovitch N, Uryniak T et al (2004) Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Ann Allergy Asthma Immunol 93:61–67. doi:10.1016/S1081-1206(10)61448-2
Wilson a M, McFarlane LC, Lipworth BJ (1998) Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity. J Allergy Clin Immunol 101:470–474. doi:10.1016/S0091-6749(98)70354-9
Sastre J, Mosges R (2012) Local and systemic safety of intranasal corticosteroids. J Investig Allergol Clin Immunol 22:1–12
Wihl J-Å, Andersson K-E, Johansson S-Å (1997) Systemic effects of two nasally administered glucocorticosteroids. Allergy 52:620–626. doi:10.1111/j.1398-9995.1997.tb01040.x
Ramoz LL, Patel-Shori NM (2014) Recent changes in pregnancy and lactation labeling: retirement of risk categories. Pharmacotherapy 34:389–395. doi:10.1002/phar.1385
Broek JL, Bousquet J, Baena-Cagnani CE et al (2010) Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 126:466–476. doi:10.1016/j.jaci.2010.06.047
Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions : explanation and elaboration. doi:10.1371/journal.pmed.1000100
Bérard A, Sheehy O, Kurzinger M-L, Juhaeri J (2016) Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes. J Allergy Clin Immunol 138:97–104.e7. doi:10.1016/j.jaci.2016.01.021
Källén BAJ, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17:255–261. doi:10.1016/S0890-6238(03)00012-1
Ellegård EK, Hellgren M, Karlsson NG (2001) Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci 26:394–400. doi:10.1046/j.1365-2273.2001.00491.x
Pelucchi Foresi a, Gherson A G, et al (1996) Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 98:274–282
Daley-Yates PT, Price AC, Sisson JR et al (2001) Beclomethasone dipropionate: Absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 51:400–409. doi:10.1046/j.0306-5251.2001.01374.x
Dawes M, Chowienczyk PJ (2001) Pharmacokinetics in pregnancy. Best Pract Res Clin Obstet Gynaecol 15:819–826. doi:10.1053/beog.2001.0231
Kallen B, Rydhstroem H, Aberg A (1999) Congenital malformations after the use of inhaled budesonide in early pregnancy. Am J Obstet Gynecol 93:392–395
Norjavaara E, De Verdier MG (2003) Normal pregnancy outcomes in a population-based study including 2968 pregnant women exposed to budesonide. J Allergy Clin Immunol 111:736–742. doi:10.1067/mai.2003.1340
Renu Lal Pharm.D (2015) Drugs in pregnancy and lactation: improved benefit-risk information. Food and Drug Administration (FDA) https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/UCM431132.pdf. Accessed 24 Jan 2017
Noordzij M, Dekker FW, Zoccali C, Jager KJ (2009) Study designs in clinical research. Nephron Clin Pract. doi:10.1159/000235610
Carlson MDA, Ph D, Morrison RS (2009) A user’ s guide to research in palliative care study design, precision, and validity in observational studies. J Palliat Med 12(1):77–82. doi:10.1089/jpm.2008.9690
Daley-Yates PT, Kunka RL, Yin Y et al (2004) Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 60:265–268. doi:10.1007/s00228-004-0763-y
Daley-yates PT, Price AC, Sisson JR et al (2001) Beclomethasone dipropionate : absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 51(5):400–409
Thorsson L, Borga O, Edsbacker S (1999) Systemic availability of budesonide after nasal administration of three different formulations; pressurized aerosol, aqueous spray pump and powder. Br J Clin Pharmacol 47:619–624. doi:10.1046/j.1365-2125.1999.00956.xf
Allen A, Down G, Newland A et al (2007) Absolute bioavailability of intranasal fluticasone furoate in healthy subjects. Clin Ther 29:1415–1420. doi:10.1016/j.clinthera.2007.07.028
Nave R, Herzog R, Laurent A, Wingertzahn MA (2009) Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy vol. Clin Ther 31:2988–2999. doi:10.1016/j.clinthera.2009.12.002
Shekelle PG, Woolf SH, Eccles M, Grimshaw J (1999) Developing clinical guidelines. West J Med 170:348–351
Lal D, Jategaonkar AA, Borish L et al (2016) Management of rhinosinusitis during pregnancy: systematic review and expert panel recommendations. Rhinology 54:99–104. doi:10.4193/Rhino15.228
Wallace DV, Dykewicz MS, Bernstein DI et al (2008) The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 122:1–84. doi:10.1016/j.jaci.2008.06.003
Walker SM, Durham SR, Till SJ et al (2011) Immunotherapy for allergic rhinitis. Clin Exp Allergy 41:1177–1200. doi:10.1111/j.1365-2222.2011.03794.x
Seidman MD, Gurgel RK, Lin SY et al (2015) Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg 152:S1–S43. doi:10.1177/0194599814561600
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
No funding was received for this study.
Conflict of interest
Authors have no conflict of interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Alhussien, A.H., Alhedaithy, R.A. & Alsaleh, S.A. Safety of intranasal corticosteroid sprays during pregnancy: an updated review. Eur Arch Otorhinolaryngol 275, 325–333 (2018). https://doi.org/10.1007/s00405-017-4785-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-017-4785-3